Interestingly, similar to observation with mouse B1 B cells, human B1 B cells appear to be minimally reliant on BAFF for survival and resisted treatment with the BAFF inhibitor belimumab in patients with systemic lupus erythematosus (62). The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.